Deanna G Teoh

Deanna G Teoh is an Associate Professor in the Department of Obstetrics, Gynecology and Women's Health at the University of Minnesota, specializing in Oncology Screening, Prevention, Etiology & Cancer Survivorship. She is affiliated with the Center for Women's Health Research Driven to Discover Research Facility (D2D) and has an extensive research portfolio focused on gynecological cancers.

Dr. Teoh's primary research interests include gynecological oncology, with specific focus on ovarian cancer, cervical cancer screening, and female genital tract malignancies. Her work spans clinical trials, cancer survivorship research, and investigations into healthcare disparities affecting cancer patients. She has particular expertise in immunotherapy approaches for gynecological cancers and has led multiple phase I/II clinical trials evaluating novel therapeutic agents.

Her recent publications (2025) demonstrate a strong focus on both clinical cancer research and healthcare equity issues. The articles span topics from discrimination experiences among LGBTQ+ patients and gynecologic cancer survivors to novel therapeutic approaches for ovarian cancer and cervical cancer. Her research combines laboratory investigation with patient-centered outcomes research, reflecting a comprehensive approach to improving women's cancer care.

Dr. Teoh is actively involved in multiple significant research projects, including a Phase I clinical study with GlaxoSmithKline, a Phase 2 pan-tumor study with Daiichi Sankyo, and the UNTOLD study focused on ovarian cancer survivorship. She also contributes to the Increasing access to cancer trials in Minnesota (InACT-MN) initiative funded by the NIH National Cancer Institute.

Her laboratory and research team focus on translating basic science discoveries into clinical applications for gynecological cancer patients, with particular attention to immunotherapy approaches and understanding treatment response biomarkers. The research facility she works within supports both clinical trials and translational research aimed at improving outcomes for women with gynecological malignancies.